Stuart L. Schreiber
Broad Institute
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Cancer, Hypoxia, and Metabolism
Strong evidence · 8 supporting papers · latest 2025
Melanoma and MAPK Pathways
Strong evidence · 8 supporting papers · latest 2025
Protein Degradation and Inhibitors
Solid evidence · 2 supporting papers · latest 2026
Signaling Pathways in Disease
Solid evidence · 1 supporting paper · latest 2026
Click Chemistry and Applications
Solid evidence · 3 supporting papers · latest 2026
Cutaneous Melanoma Detection and Management
Solid evidence · 4 supporting papers · latest 2025
Chemical Synthesis and Analysis
Solid evidence · 1 supporting paper · latest 2026
History and advancements in chemistry
Supporting evidence · 1 supporting paper · latest 2026
Publications (13)
A Versatile DNA‐Encoded Library Platform for the Discovery of Highly Cooperative Chemical Inducers of Proximity
2026DOI
Discovery of molecular glues that bind FKBP12 and structurally distinct targets using DNA-encoded libraries
2026DOIPMID 42020383
Synthesis of a nucleic acid reporter for molecular glue discovery in DNA encoded libraries
2026DOI
Suppl. Figure S8 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
2025DOI
Suppl. Figure S6 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
2025DOI
Suppl. Figure S1 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
2025DOI
Suppl. Figure S13 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
2025DOI
Suppl. Figure S7 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
2025DOI
Suppl. Figure S3 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
2025DOI
Suppl Figure S11 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
2025DOI
Suppl. Figure S9 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
2025DOI
A conversation with a chemical biology pioneer
2026DOIPMID 41652212
Author Correction: Diversity-oriented synthesis yields novel multistage antimalarial inhibitors
2025DOIPMID 41315741
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Broad Institute
Source: OpenAlex · retrieved 2026-09-29
Source: ScienceWe Extractor · retrieved 2026-09-27